Report: Pfizer nearing deal to buy Wyeth
Citing people involved in the negotiations, The New York Times reported that Pfizer agreed in principle to acquire Wyeth for $68 billion, and that the deal is expected to be announced Monday morning. Full story
Industry News Top Stories
Report: Pfizer nearing deal to buy Wyeth - (Ref. Yahoo!Finance; CNBC; Bloomberg; The Wall Street Journal; The New York Times; TheStreet.com; The Globe and Mail; Financial Times; MarketWatch) GlaxoSmithKline agrees to buy UCB products in certain emerging markets for 515 million euros - (Ref. Financial Times; Forbes; L'Echo; MarketWatch; MSN Money; The Wall Street Journal; GlaxoSmithKline; UCB) Geron stem cell-based treatment cleared by FDA for Phase I trial -(Ref. Forbes; Bloomberg; CNBC; CNN International; Financial Times; The New York Times; The Sydney Morning Herald; The Wall Street Journal; The Washington Post; Geron) Merck KGaA's cladribine significantly reduced MS relapse rates, study- (Ref. The Wall Street Journal; Bloomberg; Financial Times Deutschland; Forbes; MarketWatch; SmartMoney; Merck KGaA) Biogen Idec shares down on Merck KGaA MS drug data - (Ref. Forbes; TheStreet.com; Yahoo!Finance) Eli Lilly, Bristol-Myers Squibb withdraw US application for Erbitux in NSCLC - (Ref. CNBC; CNN Money; FXstreet; MarketWatch; Bristol-Myers Squibb) EU issues positive opinion for Roche's MabThera as first-line CLL treatment - (Ref. MarketWatch; SmartMoney; The Guardian; Roche) Acting CDC director named - (Ref. CDC; MSNBC; The Atlanta Journal-Constitution; The Wall Street Journal)